Stock BIO3 BIOTEST AG
Add to a list
To use this feature you must be a member
Log inSign up

Company Biotest AG

Equities

BIO3

DE0005227235

Pharmaceuticals

Market Closed - Xetra
Other stock markets
 11:36:26 2024-04-19 am EDT 		5-day change 1st Jan Change
28.6 EUR -0.35% Intraday chart for Biotest AG -0.69% -7.74%
Apr. 19 Biotest Launches New Plasma Collection Center in Germany MT
Mar. 28 Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. It develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Number of employees: 2,426

Sales per Business

EUR in Million2022Weight2023Weight Delta
European Union
38.0 %
- - 260 38.0 % -
Rest of the World
34.2 %
- - 234 34.2 % -
Stateless
27.8 %
- - 190 27.8 % -

Sales per region

EUR in Million2022Weight2023Weight Delta
Rest of the World
34.2 %
-- 234 34.2 % -
Stateless
27.8 %
-- 190 27.8 % -
Germany
20.5 %
150 29.0 % 141 20.5 % -6.08%
European Union
17.5 %
-- 120 17.5 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 19,785,726 11,238,292 ( 56.80 %) 0 29.83 %
Stock B 1 19,785,726 565,872 ( 2.860 %) 0

Shareholders

NameEquities%Valuation
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
2.032 %
401,990 2.032 % 12 M €
Knoesel & Ronge Vermögensverwaltung GmbH & Co. KG
1.693 %
334,968 1.693 % 10 M €
FPS Vermögensverwaltung GmbH
1.035 %
204,743 1.035 % 6 M €
Ersel Asset Management SGR SpA
0.9923 %
196,342 0.9923 % 6 M €
BNP PARIBAS ASSET MANAGEMENT Netherlands NV
0.5421 %
107,256 0.5421 % 3 M €
Mannheimer Asset Management KAGmbH
0.4992 %
98,774 0.4992 % 3 M €
Oddo BHF Asset Management GmbH
0.4862 %
96,202 0.4862 % 3 M €
National Treasury Management Agency (Invt Mgmt)
0.3291 %
65,123 0.3291 % 2 M €
UBS Asset Management (Deutschland) GmbH
0.2216 %
43,844 0.2216 % 1 M €
HSBC Trinkaus & Burkhardt (International) SA
0.1462 %
28,921 0.1462 % 837 089 €
NameEquities%Valuation
LBBW Asset Management Investmentgesellschaft mbH
9.941 %
1,966,983 9.941 % 90 M €
BayernInvest Kapitalverwaltungsgesellschaft mbH
5.649 %
1,117,599 5.649 % 51 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
4.000 %
791,352 4.000 % 36 M €
Grossbötzl, Schmitz & Partner Corporate Finance GmbH & Co. KG
0.7080 %
140,081 0.7080 % 6 M €
HSBC Trinkaus & Burkhardt (International) SA
0.5724 %
113,247 0.5724 % 5 M €
UBS Asset Management (Deutschland) GmbH
0.2578 %
51,000 0.2578 % 2 M €
Union Investment Institutional GmbH
0.1061 %
21,000 0.1061 % 961 632 €
Helaba Invest Kapitalanlagegesellschaft mbH
0.0758 %
15,000 0.0758 % 686 880 €
Arvernus Capital AG
0.0452 %
8,934 0.0452 % 409 106 €
PEH Wertpapier AG (Austria)
0.0392 %
7,748 0.0392 % 354 796 €

Company contact information

Biotest AG

Landsteinerstrasse 5

63303, Dreieich

+49 61 03 801 0

http://www.biotest.de
address Biotest AG(BIO3)

Group companies

NameCategory and Sector
Biotest Austria Gmbh

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Biotest AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
28.6 EUR
Average target price
37 EUR
Spread / Average Target
+29.37%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BIOTEST AG Stock Biotest AG
-7.74% 1.49B
CSL LIMITED Stock CSL Limited
-5.99% 84.46B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.85B
BIOGEN INC. Stock Biogen Inc.
-24.88% 27.69B
UCB Stock UCB
+53.61% 24.28B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-8.08% 17.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-33.74% 13.67B
INCYTE CORPORATION Stock Incyte Corporation
-16.63% 11.86B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.19% 11.79B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
-2.25% 8.07B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. BIO3 Stock
  4. Company Biotest AG